Serum levels of soluble B and T lymphocyte attenuator predict overall survival in patients undergoing immune checkpoint inhibitor therapy for solid malignancies.
Int J Cancer
; 149(5): 1189-1198, 2021 09 01.
Article
in En
| MEDLINE
| ID: mdl-33890289
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukocytes, Mononuclear
/
Receptors, Immunologic
/
Biomarkers, Tumor
/
Immune Checkpoint Inhibitors
/
Neoplasms
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Int J Cancer
Year:
2021
Document type:
Article